MTOR and osteosarcoma: Reports state that DRD2 on the cell membrane can inhibit tumor growth by downregulating eEF1A2 [127], whereas eEF1A2 increases osteosarcoma progression and degradation by triggering the Akt/mTOR signaling pathway [128], highlighting DRD2's anti-osteosarcoma effects.